Section 301 and medical consumable tariffs reach 100% on Chinese syringes
Oral Dosing Syringes And Cups →The Biden administration extended Section 301 punitive tariffs on Chinese health care imports, including an initial 50% tariff on syringes and needles effective in 2024. Web findings highlight that tariffs on syringes and needles from China have reached 100%. Additionally, the FDA scrutinized plastic syringes made in China following performance issues identified in March.
Severity: how big the impact would be if this plays out.
Likelihood: how probable the engine judges it is to happen or persist.
Spend exposed: the share of your annual category spend this flags.
Bolster supply chain resiliency and evaluate domestic or alternative foreign sourcing
Organizations relying heavily on foreign medical equipment imports must mitigate cost increases and supply chain risks tied to elevated tariffs and quality scrutiny.
Source · realeconomy.rsmus.com
Source · crowell.com
Source · mcdermottlaw.com
ARTICLE / CLIENT ALERT # President Trump imposes Section 232 tariffs on pharmaceuticals: What importers need to know April 20, 2026 Read time: 7 min On April 2, 2026, President Trump issued a proclamation imposing tariffs on patented pharmaceutical products and their ingredients under Section 232 of the Trade Expansion Act of 1962. The tariffs, which can reach as high as 100%, were imposed to
Source · clinicalleader.com
# July Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing By [Mathini Ilancheran](/author/mathini-ilancheran), senior delivery lead - research, R&D, Beroe Inc. Editor’s note: This guest column is a follow-up to “U.S. Drug Tariffs: Implications for Pharma and Outsourcing.” On July 21, 2026 President Trump announced that imported generic drugs will remain duty-free